FDA Inspection 844409 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA completed an inspection of IPR Pharmaceuticals, Inc. on July 29, 2013 in Canovanas, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance